MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Capricor Or Sarepta: Two DMD Stocks Enter A High-Stakes Week – Which One Has More Upside? ↗
Via Stocktwits
Tickers CAPR
Exposures Product Safety
News headline image
Nasdaq, S&P 500 Futures Fall On Tariff, Iran Tensions: Why NVDA, NFLX, HON, IBRX, MLTX Are On Traders' Radar Today ↗
Via Stocktwits
Topics Artificial Intelligence ETFs Government
Tickers ARDX CAPR DE DIA HON IBRX
Exposures Artificial Intelligence Political Product Safety
News headline image
VNDA Stock Soars 40% Overnight After Bysanti Approval: What’s The Next Catalyst And How Much Upside Remains? ↗
Via Stocktwits
Tickers VNDA
Exposures Product Safety
News headline image
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers DOCS QURE
Exposures Financial Legal Product Safety
News headline image
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers DOCS QURE
Exposures Financial Legal Product Safety
News headline image
Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief
Via PRLog
Tickers AMZN
Exposures Product Safety
News headline image
If You'd Invested $1,000 in Ford 5 Years Ago, Here's How Much You'd Have Today ↗
Via The Motley Fool
Topics Electric Vehicles Product Recall
Tickers F
Exposures Electric Vehicles Legal Product Safety
News headline image
SVRA Stock Rises After Hours As FDA Grants Priority Review For Lung Disorder Therapy ↗
Via Stocktwits
Topics Intellectual Property Lawsuit
Tickers IWM SVRA VTI
Exposures Financial Intellectual Property Legal
News headline image
VNDA Stock Rallies After-Hours As FDA Approves Schizophrenia, Bipolar Disorder Drug ↗
Via Stocktwits
Tickers IWM VNDA VTI
Exposures Product Safety
News headline image
U.S. Q4 GDP Misses Expectations: The 1.4% Growth Slump and the 2026 Outlook
Via MarketMinute
Topics Artificial Intelligence Economy Regulatory Compliance
Tickers BA GS JPM LMT NOC NVDA
Exposures Artificial Intelligence Economy Interest Rates
News headline image
Sarepta Hits Fresh Hurdle As Court Revives Patent Lawsuit With Regenxbio Over Muscular Disorder Therapy ↗
Via Stocktwits
Topics Intellectual Property Lawsuit
Tickers RGNX SRPT
Exposures Financial Intellectual Property Legal
News headline image
Teva Pharmaceuticals Seeks FDA Greenlight For New Schizophrenia Treatment ↗
Via Stocktwits
Tickers EFA IEFA TEVA
Exposures Product Safety
News headline image
Praxis Precision Shares Rally On Price Target Hikes: Analyst Sees Upside As High As 100% For Stock ↗
Via Stocktwits
Tickers PRAX WFC
Exposures Product Safety
News headline image
What's Going On With GE HealthCare Technologies Stock? ↗
Via Benzinga
Tickers GEHC
Exposures Product Safety
News headline image
Moment of Clarity Publishes New Website Resource Examining Patient Experiences During Spravato® Treatment Sessions
Via Press Advantage
Exposures Product Safety
News headline image
This High-Yield Dividend King Has 56 Years of Raises and Wall Street Is Screaming ‘Buy’
Via Barchart.com
Tickers MO PM
Exposures Product Safety
News headline image
FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer ↗
Via Benzinga
Exposures Product Safety
News headline image
ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? ↗
Via Stocktwits
Topics Earnings Intellectual Property
Tickers ARDX IWM IWO VXF XBI
Exposures Financial Intellectual Property Product Safety
News headline image
Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
Via Newsfile
Tickers TLTFF TSX-V:TLT
Exposures Product Safety
News headline image
GM Recalls 43K SUVs Over Transmission Defect That Could Lock Rear Wheels ↗
Via Benzinga
Topics Product Recall
Tickers GM
Exposures Legal Product Safety
News headline image
Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? ↗
Via Stocktwits
Topics Earnings
Tickers TNDM
Exposures Financial Product Safety
News headline image
Moderna’s Q4 Earnings Call: Our Top 5 Analyst Questions
Via StockStory
Topics Earnings
Tickers MRNA
Exposures COVID-19 Financial Product Safety
News headline image
CAPR Stock Rallied Nearly 30% So Far This Week — Here’s The February FDA Catalyst Investors Are Betting On ↗
Via Stocktwits
Tickers CAPR
Exposures Product Safety
News headline image
Why CADL Stock Plunged Nearly 15% In After-Hours Trading Today ↗
Via Stocktwits
Tickers CADL
Exposures Product Safety
News headline image
Is Viking Therapeutics Stock Really Going to $125? ↗
Via The Motley Fool
Tickers LLY MMM VKTX
Exposures Product Safety
Oberheiden P.C. Now Offering FDA 510k Submissions
Via AB Newswire
Exposures Product Safety
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Showcased for Advancing Innovative ECG Platform
Via Investor Brand Network
Topics Intellectual Property
Tickers BEAT
Exposures Intellectual Property Product Safety
News headline image
CORT Stock Drops After Appeals Court Sides With Teva In Korlym Patent Fight ↗
Via Stocktwits
Topics Intellectual Property
Tickers CORT IJR NFLX TEVA VTI
Exposures Intellectual Property Product Safety
News headline image
3 Stocks to Buy and Hold for 2026 and Beyond ↗
Via The Motley Fool
Topics Economy Intellectual Property
Tickers ABBV BMY LLY MS
Exposures Economy Intellectual Property Product Safety
News headline image
Cytokinetics Secures Triple Crown: EU Approval of MYQORZO Solidifies Global Reach in Cardiovascular Market
Via MarketMinute
Tickers BMY CYTK
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story